| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/18/2002 | WO2002055721A2 Modular transfection systems based on nucleoprotein filaments |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055717A2 Enhanced secretion of a polypeptide by a microorganism |
| 07/18/2002 | WO2002055709A2 Rhodococcus cloning and expression vectors |
| 07/18/2002 | WO2002055707A2 Cloning of an inhibitor of antigen-receptor signaling by a retroviral-based functional screen |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055704A2 Proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055703A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/18/2002 | WO2002055702A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055701A2 Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055699A2 Socs (suppressor of cytokine signaling) |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055697A2 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 07/18/2002 | WO2002055696A1 Mast cell surface antigen, dna thereof and antibody against the antigen |
| 07/18/2002 | WO2002055695A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055689A1 Rice sucrose transporter gene promoter |
| 07/18/2002 | WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/18/2002 | WO2002055684A2 Synthetic proteins containing a protein transduction domain |
| 07/18/2002 | WO2002055677A1 Transplantation cell kits for re-myelination in nerve cells |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 07/18/2002 | WO2002055669A2 Regulation of target protein activity through modified proteins |
| 07/18/2002 | WO2002055667A2 Identification of an advanced sleep phase syndrome gene in humans |
| 07/18/2002 | WO2002055664A2 Modulating insulin receptor signaling |
| 07/18/2002 | WO2002055658A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 07/18/2002 | WO2002055657A2 Protein-protein interactions |
| 07/18/2002 | WO2002055655A2 Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus |
| 07/18/2002 | WO2002055558A2 Novel proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055557A2 Human proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055556A2 Regulation of human voltage gated potassium channel protein kv2.2 |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055554A2 Antimicrobial peptides and derived metapeptides |
| 07/18/2002 | WO2002055553A2 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055551A1 A novel polypeptide, a human cd63 antigen 56.87 and the polynucleotide encoding the polypeptide |
| 07/18/2002 | WO2002055550A2 Crystallization and structure determination of fema and/or fema-like proteins |
| 07/18/2002 | WO2002055549A2 Systems for expression of heterologous proteins in m. capsulatus |
| 07/18/2002 | WO2002055548A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055546A1 Angiotensin converting enzyme inhibitors |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055542A2 Hpv-specific peptides, which block the binding of hpv to the host cell |
| 07/18/2002 | WO2002055539A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | WO2002055536A2 Regulation of target protein activity through modifier proteins |
| 07/18/2002 | WO2002055534A2 Haplotypes of the f2rli gene |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055109A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 07/18/2002 | WO2002055101A2 Storage stable powder compositions of interleukin-4 receptor |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002054939A2 Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
| 07/18/2002 | WO2002054938A2 Treatment of disease by inducing cell apoptosis |
| 07/18/2002 | WO2002054862A2 TRANSGENIC MICE CONTAINING Kv8.1 POTASSIUM CHANNEL ALPHA SUBUNIT GENE DISRUPTIONS |
| 07/18/2002 | WO2002048349A8 Polypeptide capable of binding to heparin |
| 07/18/2002 | WO2002044382A8 Cytokine-like proteins |
| 07/18/2002 | WO2002044198A3 Haplotypes of the slc1a4 gene |
| 07/18/2002 | WO2002037100A3 Novel applications of nickel nitrilotriacetic acid (ni-nta) resin: hemeprotein removal, recovery, and purification from biological samples |
| 07/18/2002 | WO2002034280A3 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/18/2002 | WO2002034205A3 Using heat shock proteins to increase immune response |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002033129A3 Nucleic acid amplification controls |
| 07/18/2002 | WO2002031114A3 Gene expression modulated in ileitis |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002028418B1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002027322A3 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/18/2002 | WO2002026771A3 Haplotypes of the scya7 gene |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | WO2002022159A8 Thionin as an antineoplastic and immunostimulant |
| 07/18/2002 | WO2002020597A3 Human vomeronasal receptor-5 |
| 07/18/2002 | WO2002016549A3 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 07/18/2002 | WO2002016431A3 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 07/18/2002 | WO2002010411A3 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002004488A3 Nucleic acid binding polypeptides |
| 07/18/2002 | WO2002002789A3 Compositions and methods for producing recombinant virions |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002000927A3 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 07/18/2002 | WO2002000926A8 Diagnosis of diseases associated with signal transduction |
| 07/18/2002 | WO2002000169A3 Production of vaccines using transgenic plants |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001092504A8 Triacylglycerol lipases from arabidopsis thaliana |
| 07/18/2002 | WO2001092302A3 Human cyslt2 nucleic acids, polypeptides, and uses thereof |
| 07/18/2002 | WO2001090366A3 Human polynucleotides and polypeptides encoded thereby |
| 07/18/2002 | WO2001088163A9 Method for producing recombinant expansins |
| 07/18/2002 | WO2001088137A3 Human myd88 adapter-like protein and functional fragments thereof |
| 07/18/2002 | WO2001088134A3 Novel human lipocalin homologs and polynucleotides encoding the same |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001087936A3 Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome |